Clinical Trial Update: Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing sirolimus/tacrolimus versus tacrolimus/methotrexate for GVHD prevention in transplantation; study completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia Lymphocytic Acute
• Leukemia Myeloid Acute
• Leukemia Myeloid Chronic
• Myelodysplastic Syndromes

Drugs mentioned

• Sirolimus/Tacrolimus
• Tacrolimus/Methotrexate

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute | Phase 3 | Status: COMPLETED | Results posted: 2016-03-07